Abstract
The growing prevalence of heart failure in the worldwide population coupled with its high socioeconomic burden has escalated interest in any treatment modality that can dramatically affect the estimated 50% 5-year mortality commonly associated with heart failure. Cardiac transplantation remains the definitive therapy for most patients with advanced heart failure and confers improvements in both survival and quality of life. Since the first cardiac transplant in 1967, the transplant community has been on a relentless pursuit to perfect this highly individualized and resource-heavy treatment modality. As a result of major advances in nearly every component of the heart transplant process, survival has incrementally improved in every decade, and most patients are surviving decades, and not months to years, after their transplant. This chapter examines the multitude of factors, from pre-transplant comorbidities, to surgical variables, to post-transplant management and comorbidities that have been proven to affect short-, intermediate-, and long-term survival in heart transplant recipients.
References
Alam M et al (2011) Increased incidence and mortality associated with skin cancers after cardiac transplant. Am J Transplant 11:1488–1497
Al-Kindi SG (2015) Heart transplant outcomes in patients with left ventricular non-compaction cardiomyopathy. JHLT 34:761–765
Allen J (2012) Insurance and education predict long-term serval after orthotropic heart transplantation in the United States. JHLT 31:52–60
Allen J, Weiss E, Arnaoutakis G et al (2010) The impact of race on survival after heart transplantation: an analysis of more than 20,000 patients. Ann Thorac Surg 89(6):1956–1963
Amareli C et al (2012) Early graft failure after heart transplant: risk factors and implications for improved donor-recipient matching. Interact Cardiovasc Thorac Surg 15:57–62
Ansari D et al (2015) Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab. J Heart Lung Transplant 34:1283–1291
Awad M, Czer L, De Robertis M et al (2016) Adult heart transplantation following ventricular assist device implantation: early and late outcomes. Transplant Proc 48:158–166
Bhama JK et al (2013) Heart transplantation for adults with congenital heart disease: results in the modern era. J Heart Lung Transplant 32(5):499–504
Bianco JC, Rossi PI, Belziti CA, Gracia-Fornari G, Marenchino RG (2014) Intraoperative use of several inotropes is associated with increased mid-term mortality in patients undergoing orthotopic heart transplantation. Transplant Proc 46(9):3054–3059
Castle MA et al (2011) Primary immunosuppression and outcome difference after heart transplantation: tacrolimus versus cyclosporine. Transplant Proc 43:2244–2246
Cooper L, Lu D, Mentz R et al (2016) Cardiac transplantation for older patients: characteristics and outcomes in the septuagenarian population. J Heart Lung Transplant 35(3):362–369
Coutu M, Perrault L, White M et al (2004) Cardiac transplantation for hypertrophic cardiomyopathy: a valid therapeutic option. JHLT 23:e413–e417
Crespo-Leiro MG (2014) The falling incidence of hematologic cancer after heart transplantation. Clin Transpl 28:1142–1147
Emin A et al (2011) Antithymocyte globulin induction therapy for adult heart transplantation: a UK national study. J Heart Lung Transplant 20:770–777
Fiorelli AL et al (2012) Risk factor analysis of late survival after heart transplantation according to donor profile: a multi-national retrospective study of 512 transplants. Transplant Proc 44(8):2469–2472
Forest SJ (2015) Cardiac transplantation from infected donors: is it safe? J Card Surg 30:228–295
Gass A, Emaminia A, Lanier G et al (2015) Cardiac transplantation in the new era. Cardiol Rev 23:182–188
Grimm JC (2015) MELD-XI score predicts early mortality in patients after heart transplantation. Ann Thorac Surg 100:1737–1743
Grimm JC et al (2015) The influence of institutional volume on the incidence of complications and their effect on mortality after heart transplantation. J Heart Lung Transplant 34:1390–1397
Hosenpud JD et al (1995) The registry of the ISLHT: 12th official report 1995. JHLT 14:805–815
Hunt S, Haddad F (2008) The changing face of heart transplantation. J Am Coll Cardiol 52:587–598
Khush K, Kubo J, Desai M (2012) Influence of donor and recipient sex mismatch on heart transplant outcomes: analysis of the International Society for Heart and Lung Transplantation Registry. J Heart Lung Transplant 31:459–466
Khush K, Cherikh W, Chambers D et al (2018) The international thoracic organ transplant registry of the International Society of Heart and Lung Transplantation: thirty-fifth adult heart transplantation report – 2018; focus theme: multiorgan transplantation. J Heart Lung Transplant 37(10):1155–1206
Kilic A (2012) Identifying recipients at high risk for graft failure after heart Retransplantation. Ann Thorac Surg 93:712–717
Kilic A, Conte J, Baumgartner W et al (2014) Does recipient age impact functional outcomes of orthotopic heart transplantation? Ann Thorac Surg 97:1636–1642
Kobashigowa J et al (1998) A randomized active controlled trial of MMF in heart transplant recipients: mycophenolate mofetil investigators. Transplantation 66:507–515
Kriklin JK, Pambukian SV, McGiffin DC, Benza RL (2004) Current outcomes following heart transplantation. Semin Thorac Cardiovsac Surg 16:395–403
Lund L, Edwards L, Kucheryavaya A et al (2015) The registry of the International Society for Heart and Lung Transplantation: thirty-second official adult heart transplantation report – 2015; focus theme: early graft failure. J Heart Lung Transplant 34(10):1244–1254
Luo CM (2014) The effect of statins on cardiac allograft survival. Transplant Proc 46:920–924
Madan S (2016) Donor troponin and survival after cardiac transplantation an analysis of the united network of organ sharing registry. Circ Heart Fail 9:e002909
Martinez-Selles M et al (2014) Donor/recipient sex mismatch and survival after heart transplantation: only an issue in male recipients? An analysis of the Spanish heart transplantation registry. Transpl Int 28:305–313
Pigula F, Gandhi S, Ristich J et al (2001) Cardiopulmonary transplantation for congenital heart disease in adults. JHLT 20:297–303
Potapov EF (2001) Value of cardiac troponin I and T for selection of heart donors as predictors of early graft failure. Transplantation 71:1394–1400
Quader MA, Wolfe LG, Kasirajan V (2013) Heart transplantation outcomes from cardiac arrest-resuscitated donors. JHLT 32:1090–1095
Reed R et al (2014) Cardiac size and sex-matching in heart transplantation. JACC: Heart Failure 2(1):73–83
Rosenbaum AN et al (2016) Association between early cardiac rehabilitation and long-term survival in cardiac transplant recipients. Mayo Clin Proc 91(2):149–156
Savla J (2014) Adolescent age and heart transplantation outcomes in myocarditis or congenital heart disease. JHLT 33(9):943–949
Smits JM et al (2012) Donor scoring system for heart transplantation and the impact on patient survival. JHLT 31:387–397
Sorabella R (2015) Cardiac donor risk factors predictive of short term heart transplant recipient mortality: an analysis of the united network for organ sharing database. Transplant Proc 47:e2944–e2951
Sorabella R, Yerebakan H, Walters R et al (2015) Comparison of outcomes after heart replacement therapy in patients over 65 years old. Ann Thorac Surg 99:582–589
Stobierska-Dzierzek B, Awad H, Michler RE (2005) The evolving management of acute right-sided heart failure in cardiac transplant recipients. JACC 38(4):923–931
Suryanarayana P, Copeland H, Friedman M, Copeland J (2014) Cardiac transplantation in African Americans: a single-center experience. Clin Cardiol 37(6):331–336
Tedford R (2012) Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy. JACC 59(3):289–290
Thomas H, Banner N, Murphy C et al (2012) Incidence, determinants, and outcome of chronic kidney disease after adult heart transplantation in the United Kingdom. Transplantation 93(11):1151–1157
Toyoda Y (2014) Heart-lung transplantation: adult indications and outcomes. J Thorac Dis 6(8):1138–1142
Venissa Tam B (2011) Martial status improves survival after orthotropic heart transplantation. JHLT 30:1389–1394
Weiss ES et al (2011) Creation of a quantitative recipient risk index for mortality prediction after cardiac transplantation (IMPACT). Ann Thorac Surg 92:914–922
Weiss ES et al (2012) Development of a quantitative donor risk index to predict short-term mortality in orthotopic heart transplantation. JHLT 31:266–273
Whitson BA et al (2015) Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents. Clin Transpl 29:9–17
Yardley M et al (2016) Peak oxygen uptake and self-reported physical health are strong predictors of long-term survival after heart transplantation. Clin Transpl 30:161–169
Yeen W et al (2013) Outcomes of adult orthotopic heart transplantation with extended allograft ischemic time. Transplant Proc 45:2399–2405
Yoshizawa S (2013a) Outcomes of patients having heart transplantation for lymphocytic myocarditis. Am J Cardiol 112(3):405–410
Yoshizawa SK (2013b) Hypersensitivity myocarditis and outcomes after heart transplantation. JHLT 32(5):553–559
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 This is a U.S. Government work and not under copyright protection in the U.S.; foreign copyright protection may apply
About this entry
Cite this entry
Crimm, H.A., Fiacco, N.R., Flanagan, M.C. (2020). Contemporary Survival in Heart Transplantation. In: Bogar, L., Mountis, M. (eds) Contemporary Heart Transplantation. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-33280-2_35-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-33280-2_35-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33280-2
Online ISBN: 978-3-319-33280-2
eBook Packages: Springer Reference MedicineReference Module Medicine